Covid-19: Prednisone Linked To Reduced Risk Of Death

1
>>Follow Matzav On Whatsapp!<<

Dexamethasone isn’t the only steroid that has shown promise in the battle against COVID-19.

Researchers at the Albert Einstein College of Medicine and Montefiore Health System led a study in which most of their patients took prednisone, another steroid in the same family as dexamethasone, and found patients with high inflammation levels were associated with a 75% reduction in risk of going on mechanical ventilation or dying.

The study, published in the peer-reviewed Journal of Hospital Medicine, also sought to pinpoint a window in which these steroids would be the most beneficial to patients with COVID-19, the illness caused by SARS-CoV-2 virus.

Authors of the Einstein-Montefiore study found a simple blood test could dictate when a doctor should treat their patient with steroids. The blood test measures levels of C-reactive protein, which the liver produces in response to inflammation.

Read more at USA Today

{Matzav.com}

 

1 COMMENT

  1. No one cares about treating this horrible disease nor about the people who are painfully affected, only about political elections, cheap “miracle” solutions, and being free to spread their disease to others by going around without a mask.

LEAVE A REPLY

Please enter your comment!
Please enter your name here